The point is that there is, indeed, “bad” cholesterol—even “ultra-bad” cholesterol—but we’re not accomplishing anything by using a shotgun pharmaceutical approach that lowers total cholesterol. We need to get into the weeds and figure out what exactly is causing any damage, and we now have sophisticated tools to do just that. The old approach is akin to clipping a hangnail with an axe—and what’s more, the old approach has significant unwanted side effects,
